Salta al contenuto principale

ADCY5-related dyskinesia

ADCY5-related dyskinesia is a movement disorder; the term "dyskinesia" refers to abnormal involuntary movements. The abnormal movements that occur in ADCY5-related dyskinesia typically appear as sudden (paroxysmal) jerks, twitches, tremors, muscle tensing (dystonia), or writhing (choreiform) movements, and can affect the limbs, neck, and face.

Descrizione

ADCY5-related dyskinesia is a movement disorder; the term "dyskinesia" refers to abnormal involuntary movements. The abnormal movements that occur in ADCY5-related dyskinesia typically appear as sudden (paroxysmal) jerks, twitches, tremors, muscle tensing (dystonia), or writhing (choreiform) movements, and can affect the limbs, neck, and face.

The abnormal movements associated with ADCY5-related dyskinesia usually begin between infancy and late adolescence. They can occur continually during waking hours, and frequently also disturb sleep. The involuntary movements often occur when changing position, such as from sitting to standing, or when deliberately making other movements.

Severely affected infants may experience weak muscle tone (hypotonia) and delay in development of motor skills such as crawling and walking; later, these individuals may have difficulties with activities of daily living and may eventually require a wheelchair. In more mildly affected individuals, the condition has little impact on walking and other motor skills, although the abnormal movements can lead to clumsiness or difficulty with social acceptance in school or other situations.

In some people with ADCY5-related dyskinesia, the disorder is generally stable throughout their lifetime. In others, it slowly gets worse (progresses) in both frequency and severity before stabilizing or even improving in middle age. Anxiety, fatigue, and other stress can temporarily increase the severity of the signs and symptoms of ADCY5-related dyskinesia, while some affected individuals may experience remission periods of days or weeks without abnormal movements. Life expectancy is not usually affected by ADCY5-related dyskinesia, and most people with this condition have normal intelligence.

Modelli di ereditarietà

The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.

Altri nomi

Familial dyskinesia with facial myokymia

FDFM

Related patient information and medicines

Medicinali antipsicotici

Patient information leaflet

Medicinali antipsicotici

Movimento disorders develop in some cases. These include: Parkinsonismo - this can cause symptoms similar to those that occur in people with Parkinson malattia Parkinson disease - for example, tremor and tensione muscolare stiffness. Discinesia tardiva (TD) - this is a movement disorder that can occur in some people who have taken antipsychotics for several.

Blefarospasmo

Patient information leaflet

Blefarospasmo

Discinesia tardiva (see below). Tourette's syndrom... Deep brain stimulation Deep brain stimulation has been used (very rarely) for blepharospasm which is a part of Meige syndrome. Is tardive dyskinesia related per blepharospasm. Discinesia tardiva is a movement disorder that results from taking certain medication, particularly a class of medicines.

Malattia di Parkinson

Patient information leaflet

Malattia di Parkinson

L main symptoms of Parkinson's disease are usually stiffness, shaking (tremor), and slowness of movement. Malattia di Parkinson è a progressive neurological degeneration of certain cells (called dopaminergic cells) within a specific part of the brain (substantia nigra). Three common PD symptoms that gradually develop are: Slowness of movement.

Mutismo selettivo

Patient information leaflet

Mutismo selettivo

Mutismo selettivo involves being unable to speak or communicate in specific social situations, come at school, work, or in the community.

Posso prendere Lansoprazolo e Quetiapina insieme?

Patient information leaflet

Posso prendere Lansoprazolo e Quetiapina insieme?

Assumere lansoprazole and quetiapine together may increase the risk of a rare but serious heart rhythm problem. It can also potentially change how much quetiapine is absorbed into your body. Why this happens Lansoprazole Lansoprazole to reduce stomach acid reduces stomach acid, which can change how quetiapine Quetiapine dissolves and is absorbed. By.

Posso prendere Atorvastatina e Maitake insieme?

Patient information leaflet

Posso prendere Atorvastatina e Maitake insieme?

Assumere maitake mushrooms alongside atorvastatin potrebbe increase the risk of muscle-related side effects or fegato irritation. It may also cause your blood sugar or cholesterol levels to drop lower than expected. Speak to your doctor before taking atorvastatin Atorvastatin tablets and maitake together as combining them may increase the risk of.

Ulteriori letture e riferimenti

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
  • 18 Ago 2023 | Ultima versione
  • 1 lug 2015 | Pubblicato originariamente

Partecipa alla conversazione

Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.

Avvertenza: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmacia online, trattamenti e servizi sanitari

Accesso semplice a trattamenti affidabili e servizi sanitari online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Iscriviti alla newsletter di Patient

La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.